SCHEMBL6554633

SCHEMBL6554633

CCS(=O)(=O)NC(C(=O)NCCc1ccc(OCCCc2cccc(C(F)(F)F)c2)c(OC)c1)C(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PTGER1 P34995 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
CTSD P07339 1/20 0.43
ADRB2 P07550 1/20 0.42
DRD2 P14416 1/20 0.42
DRD1 P21728 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
TSHR P16473 1/20 0.42
MAPT P10636 1/20 0.42
MTNR1A P48039 3/20 0.41
MTNR1B P49286 3/20 0.41
PLAAT3 P53816 1/20 0.41
PLAAT5 Q96KN8 1/20 0.41
PLAAT2 Q9NWW9 1/20 0.41
PLAAT4 Q9UL19 1/20 0.41
ROCK2 O75116 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6554629 1.00 KDM4E (0.50) KDM4ETDP1PTGER1SMN1; SMN2LMNA
SCHEMBL6555530 0.87 SMN1; SMN2 (0.47) SMN1; SMN2LMNAADRB2DRD2DRD1
SCHEMBL7782483 0.86 KDM4E (0.47) KDM4ETDP1PTGER1SMN1; SMN2LMNA
SCHEMBL7605247 0.82 MTNR1A (0.56) SMN1; SMN2LMNATSHRMTNR1AMTNR1B
SCHEMBL6555077 0.82 ALDH1A1 (0.46) SMN1; SMN2LMNATSHRMAPTMEN1
SCHEMBL6555072 0.82 ALDH1A1 (0.46) SMN1; SMN2LMNATSHRMAPTMEN1
SCHEMBL6556087 0.81 ADRB2 (0.48) PTGER1SMN1; SMN2LMNAADRB2MAPT
SCHEMBL7155558 0.81 ADRB2 (0.48) PTGER1SMN1; SMN2LMNAADRB2MAPT
SCHEMBL6554951 0.81 ALDH1A1 (0.48) SMN1; SMN2LMNAMAPTMEN1KMT2A
SCHEMBL6556788 0.81 ALDH1A1 (0.60) PTGER1SMN1; SMN2LMNACTSDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1135369-B1 ALPHA-SULFIN- AND ALPHA-SULFONAMINO ACID AMIDES SYNGENTA PARTICIPATIONS AG (CH) 2004-02-25 EP disclosed
US-20020099241-A1 For use in protecting plants against infestation by phytopathogenic microorganisms SYNGENTA PARTICIPATIONS AG (CH) 2002-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099241-A1 For use in protecting plants against infestation by phytopathogenic microorganisms CBR1, CBR3, MSR1 KDM4E 3338/4885TDP1 4292/4885PTGER1 2038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.